Recent Advances: Heterocycles in Drugs and Drug Discovery
Conflicts of Interest
References
- Meanwell, N.A. Applications of Bioisosteres in the Design of Biologically Active Compounds. J. Agric. Food Chem. 2023, 71, 18087–18122. [Google Scholar] [CrossRef] [PubMed]
- Guan, Q.; Xing, S.; Wang, L.; Zhu, J.; Guo, C.; Xu, C.; Zhao, Q.; Wu, Y.; Chen, Y.; Sun, H. Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application. J. Med. Chem. 2024, 67, 7788–7824. [Google Scholar] [CrossRef] [PubMed]
- Betancourt-Conde, I.; Avitia-Domínguez, C.; Hernández-Campos, A.; Castillo, R.; Yépez-Mulia, L.; Oria-Hernández, J.; Méndez, S.T.; Sierra-Campos, E.; Valdez-Solana, M.; Martínez-Caballero, S.; et al. Benzimidazole Derivatives as New and Selective Inhibitors of Arginase from Leishmania mexicana with Biological Activity against Promastigotes and Amastigotes. Int. J. Mol. Sci. 2021, 22, 13613. [Google Scholar] [CrossRef] [PubMed]
- Al-Wahaibi, L.H.; Abou-Zied, H.A.; Beshr, E.A.M.; Youssif, B.G.M.; Hayallah, A.M.; Abdel-Aziz, M. Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis–Pyrazoline Derivatives as Dual EGFR/BRAFV600E Inhibitors. Int. J. Mol. Sci. 2023, 24, 9104. [Google Scholar] [CrossRef] [PubMed]
- Rotella, D.P. Chapter Four—Heterocycles in drug discovery: Properties and preparation. In Advances in Heterocyclic Chemistry; Meanwell, N.A., Lolli, M.L., Eds.; Academic Press: Cambridge, MA, USA, 2021; Volume 134, pp. 149–183. [Google Scholar] [CrossRef]
- Kumar, D.; Sharma, P.; Singh, H.; Nepali, K.; Gupta, G.K.; Jain, S.K.; Ntie-Kang, F. The value of pyrans as anticancer scaffolds in medicinal chemistry. RSC Adv. 2017, 7, 36977–36999. [Google Scholar] [CrossRef]
- Pal, P. Recent advances in syntheses and antibacterial activity of novel furan derivatives. In Heterocyclic Chemistry—New Perspectives; IntechOpen Limited: London, UK, 2024. [Google Scholar] [CrossRef]
- Amata, S.; Calà, C.; Rizzo, C.; Pibiri, I.; Pizzo, M.; Buscemi, S.; Palumbo Piccionello, A. Synthesis and Antibacterial Activity of Mono- and Bi-Cationic Pyridinium 1,2,4-Oxadiazoles and Triazoles. Int. J. Mol. Sci. 2024, 25, 377. [Google Scholar] [CrossRef] [PubMed]
- Campofelice, A.; Lentini, L.; Di Leonardo, A.; Melfi, R.; Tutone, M.; Pace, A.; Pibiri, I. Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs). Int. J. Mol. Sci. 2019, 20, 3329. [Google Scholar] [CrossRef] [PubMed]
- Rizzo, C.; Amata, S.; Pibiri, I.; Pace, A.; Buscemi, S.; Palumbo Piccionello, A. FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022. Int. J. Mol. Sci. 2023, 24, 7728. [Google Scholar] [CrossRef] [PubMed]
- Abbas, A.A.; Farghaly, T.A.; Dawood, K.M. Recent advances on anticancer and antimicrobial activities of directly-fluorinated five-membered heterocycles and their benzo-fused systems. RSC Adv. 2024, 14, 19752–19779. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pibiri, I. Recent Advances: Heterocycles in Drugs and Drug Discovery. Int. J. Mol. Sci. 2024, 25, 9503. https://doi.org/10.3390/ijms25179503
Pibiri I. Recent Advances: Heterocycles in Drugs and Drug Discovery. International Journal of Molecular Sciences. 2024; 25(17):9503. https://doi.org/10.3390/ijms25179503
Chicago/Turabian StylePibiri, Ivana. 2024. "Recent Advances: Heterocycles in Drugs and Drug Discovery" International Journal of Molecular Sciences 25, no. 17: 9503. https://doi.org/10.3390/ijms25179503